The product has received approval from Drug Control Department
Anglo-French Drugs & Industries has launched a new product AFD-NP in the neuropathic pain segment. AFD-NP is a combination of Nortriptyline + Pregabalin which is indicated to resolve moderate to severe neuropathic pain. This product has received approval from Drug Control Department.
Abhay Kanoria, CMD, Anglo French Drugs & Industries, “Neuropathic pain or neuropathy is commonly associated with diabetes. It has become a common disease in India and other parts of the world due to the increasing incidence of Diabetes. Looking at the enormous number of patients suffering from moderate to severe neuropathy, we felt the need of launching a product in this segment to alleviate the suffering of millions. With the launch of AFD-NP, we hope that we can help patients in dealing with their discomfort with less or no side effects and live a pain-free life. Our product is formulated with the highest quality with cutting-edge technology and we are positive about its success in this segment shortly.”
